Articles tagged "Infection"

2021 American Transplant Congress
Outcomes of Abdominal Transplant Recipients Who Receive Organs from Donors with Positive Cultures
A. Perez Cortes Villalobos, A. Humar, D. Kumar
University Health Network, Toronto, ON, Canada
*Purpose: Due to limited organ availability, use of donors with positive bacterial cultures is common practice. One of the main concerns is transmission to the…
2021 American Transplant Congress
Risk Factors Associated with Severe COVID19 Illness in Kidney Transplant Recipients
E. Abuhelaiqa, M. Alkadi, H. Tohid, R. Elidrisi, R. Abdul Rahiman, M. F. Elshirbeny, T. A. Ghonaimi, A. I. Hamad, A. Nauman, A. A Aziz, O. Fituri, M. Asim, M. A. Othman, H. Al-Malki
Hamad Medical Corporation, Doha, Qatar
*Purpose: COVID19 is an acute respiratory infection that is caused by the SARS-COV-2 that has been shown to be highly contagious and poses a significant…
2021 American Transplant Congress
COVID-19 in Kidney Transplant Recipients in the Southeastern United States: A Single Center Experience
K. R. Kumm, S. H. Shawar, R. C. Forbes, B. P. Concepcion
Vanderbilt University Medical Center, Nashville, TN
*Purpose: The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19, has emerged as a viral pandemic and brought unprecedented challenges worldwide on…
2021 American Transplant Congress
Cytomegalovirus Nephritis: Epidemiology and Outcomes of an Uncommon Diagnosis
K. J. Swanson, A. Djamali, A. Ghaffar, F. Aziz, N. Garg, M. Mohamed, D. A. Mandelbrot, M. Jorgensen, S. Parajuli
Division of Nephrology, University of Wisconsin-Madison, Madison, WI
*Purpose: Cytomegalovirus (CMV) nephritis is an uncommon end-organ manifestation of CMV disease. Due to this, associated outcomes have not been completely elucidated.*Methods: This was a…
2021 American Transplant Congress
SARS-CoV-2 Infection Among Kidney Transplant Recipients: A Multicenter Brazilian Cohort Study
T. Sandes-Freitas¹, J. Medina-Pestana², o. COVID-19 Brazil Study Group³
¹Universidade Federal do Ceará, Fortaleza, Brazil, ²Hospital do Rim, São Paulo, Brazil, ³Brazil, Brazil, Brazil
*Purpose: Limited data are available on COVID-19 clinical presentation and outcomes among kidney transplant (KT) recipients.*Methods: Multicenter Brazilian cohort of KT patients with laboratory-confirmed SARS-CoV-2…
2021 American Transplant Congress
Criteria and Practice Patterns for Accepting Living Donors with Prior Covid-19: A National Survey
A. Jawed¹, M. Y. Jan², N. Barros², O. Adebiyi², A. Diez³, J. Fridell², W. Goggins², M. Yaqub², M. A. Mujtaba⁴, T. Taber², V. Kumar⁵, K. Lentine⁶, A. Sharfuddin²
¹Wayne State University, Detroit, IN, ²Indiana University School of Medicine, Indianapolis, IN, ³The Ohio State University, Columbus, OH, ⁴UTMB Galveston, Galveston, TX, ⁵University of Alabama, Birmingham, AL, ⁶St. Louis University, St. Louis, MO
*Purpose: A critical question facing transplant programs is if, when and how to safely accept living kidney donors (LKD) who have a history and recovered…
2021 American Transplant Congress
COVID-19 Presentation and Severity Within One Year of Pancreas and Kidney Transplantation
H. Sarumi, J. Fisher, B. Johnson, T. Pruett
University of Minnesota, Minneapolis, MN
*Purpose: The current pandemic has created uncertainty of induction regimen impact upon severity of COVID-19 disease. Our experience with COVID-19 infection was reviewed to stratify…
2021 American Transplant Congress
Profile of SARS-CoV-2 Antibodies in Patients Awaiting Kidney Transplantation
L. Muir¹, A. Jaffer², C. Rees-Spear¹, V. Gopalan², F. Chang², G. Vaitkute¹, R. Fernando³, C. Roustan⁴, A. Rosa⁴, C. Earl⁴, A. Salama², P. Cherepanov⁴, L. E. McCoy¹, R. Motallebzadeh²
¹Institute of Immunity & Transplantation, University College London, London, United Kingdom, ²Nephrology & Transplantation, Royal Free London Hospital NHS Trust, London, United Kingdom, ³Anthony Nolan Institute, Royal Free London Hospital NHS Trust, London, United Kingdom, ⁴The Francis Crick Institute, London, United Kingdom
*Purpose: Patients with end-stage kidney disease (ESKD) represent an extremely vulnerable group with many risk factors for adverse outcomes following SARS-CoV-2 infection. Key questions pertaining…
2021 American Transplant Congress
Impact of a Pharmacist-driven Immunization Clinic on Vaccination Rates in Pre-liver Transplant Patients
A. Poparad-Stezar¹, B. Summers¹, M. Fitzmaurice¹, K. Hakamiun², N. Sulejmani³, A. Jantz¹
¹Henry Ford Hospital, Detroit, MI, ²Select Medical, Wyandotte, MI, ³CareDx, Inc., Sterling Heights, MI
*Purpose: Infectious diseases are a leading cause of morbidity and mortality among patients with end-stage liver disease (ESLD). Vaccination data of ESLD patients pre- and…
2021 American Transplant Congress
Clinical Outcomes of Solid Organ Transplant Recipients with Severe Acute Respiratory Syndrome Coronavirus 2
R. Adekunle, D. Jandhyala, J. Lewis
Medicine, Division of Infectious Diseases, Medical University of South Carolina, Charleston, SC
*Purpose: The Centers for Disease Control and Prevention identified solid organ transplant (SOT) recipients as persons at high risk to develop severe illness secondary to…